Altmetric

The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumors with high dose chemotherapy as consolidation- a non-cisplatin- based induction approach.

File Description SizeFormat 
ipo.pdfAccepted version568.57 kBAdobe PDFView/Open
Title: The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumors with high dose chemotherapy as consolidation- a non-cisplatin- based induction approach.
Authors: Badreldin, W
Krell, J
Chowdhury, S
Harland, S
Mazhar, D
Harding, V
Frampton, A
Wilson, P
Berney, D
Stebbing, J
Shamash, J
Item Type: Journal Article
Issue Date: 28-Nov-2014
Date of Acceptance: 21-Nov-2014
URI: http://hdl.handle.net/10044/1/21700
DOI: https://dx.doi.org/10.1111/bju.13004
ISSN: 1464-4096
Publisher: Wiley
Start Page: 418
End Page: 423
Journal / Book Title: BJU International
Volume: 117
Issue: 3
Copyright Statement: © 2015 Wiley. This is the peer reviewed version of the following article: The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumors with high dose chemotherapy as consolidation- a non-cisplatin- based induction approach, BJU International, 2015, which has been published in final form at https://dx.doi.org/10.1111/bju.13004. This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.
Sponsor/Funder: National Institute for Health Research
Cancer Research UK
Funder's Grant Number: NIHR-RP-011-053
C27532/A14549
Keywords: cisplatin resistance
germ cell tumours
relapse
germ cell tumors
Urology & Nephrology
1103 Clinical Sciences
Publication Status: Published
Appears in Collections:Division of Surgery
Division of Cancer
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx